You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR ALCAINE


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for ALCAINE

Trial ID Title Status Sponsor Phase Start Date Summary
NCT02951351 ↗ Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections Completed Research to Prevent Blindness N/A 2016-10-12 The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.
NCT02951351 ↗ Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections Completed VitreoRetinal Surgery, PA N/A 2016-10-12 The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.
NCT02951351 ↗ Topical Proparacaine Eye Drops to Improve the Experience of Patients Undergoing Intravitreal Injections Completed Mayo Clinic N/A 2016-10-12 The specific aims of this study are to compare patient experience with and without a proparacaine drop after povidone iodine.
NCT02973581 ↗ SPI-directed Analgesia for Vitreoretinal Surgeries Completed Silesian University of Medicine N/A 2016-02-01 The aim of this randomized trial is to assess the efficacy of SPI-directed analgesia for vitreoretinal surgeries (VRS), presence of PONV and oculocardiac reflex (OCR) and compare Numerical Rating Scale (NRS) with Surgical Pleth Index (SPI) for monitoring pain perception postoperatively. Patients received general anaesthesia alone or combined with either preemptive analgesia using topical solution of 0,5% proxymetacaine or peribulbar block (0,5% bupivacaine with 2% lidokaine) or preemptive intravenous infusion of 1,0 g of metamizol or preemptive intravenous infusion of acetaminophen in a doseof 10-15mg/kg of body weight.
NCT02973581 ↗ SPI-directed Analgesia for Vitreoretinal Surgeries Completed Medical University of Silesia N/A 2016-02-01 The aim of this randomized trial is to assess the efficacy of SPI-directed analgesia for vitreoretinal surgeries (VRS), presence of PONV and oculocardiac reflex (OCR) and compare Numerical Rating Scale (NRS) with Surgical Pleth Index (SPI) for monitoring pain perception postoperatively. Patients received general anaesthesia alone or combined with either preemptive analgesia using topical solution of 0,5% proxymetacaine or peribulbar block (0,5% bupivacaine with 2% lidokaine) or preemptive intravenous infusion of 1,0 g of metamizol or preemptive intravenous infusion of acetaminophen in a doseof 10-15mg/kg of body weight.
NCT03949101 ↗ Atropine for Children and Adolescent Myopia Progression Study Unknown status Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine Phase 4 2019-05-08 Investigators are going to conduct a randomized controlled trial that myopic children are randomly allocated into two groups: combined use of 1% atropine and 0.01% atropine (experimental group) and 0.01% atropine (control group) in order to explore a better way to control myopia progression and eliminate adverse effects at the same time, provide reliably evidence for clinical guideline of atropine use in children, and investigate the mechanism of atropine on eyes.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for ALCAINE

Condition Name

Condition Name for ALCAINE
Intervention Trials
Dacryocystitis 2
Dacryostenosis 2
Epiphora 2
Myopia 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for ALCAINE
Intervention Trials
Lacrimal Apparatus Diseases 2
Dacryocystitis 2
Parotitis 1
Nausea 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for ALCAINE

Trials by Country

Trials by Country for ALCAINE
Location Trials
United States 3
China 1
Poland 1
Taiwan 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for ALCAINE
Location Trials
Louisiana 1
Michigan 1
Minnesota 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for ALCAINE

Clinical Trial Phase

Clinical Trial Phase for ALCAINE
Clinical Trial Phase Trials
Phase 4 3
N/A 2
Early Phase 1 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for ALCAINE
Clinical Trial Phase Trials
Recruiting 3
Completed 2
Unknown status 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ALCAINE

Sponsor Name

Sponsor Name for ALCAINE
Sponsor Trials
Medical University of Silesia 1
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 1
Shanghai Eye Disease Prevention and Treatment Center 1
[disabled in preview] 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for ALCAINE
Sponsor Trials
Other 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.